Safety and efficacy of ethynodiol diacetate, 1 mg, plus ethinyl estradiol, 35 micrograms. A phase IV trial. Introduction
Friedman, A.J.
Journal of reproductive medicine 36(4 Suppl): 323-324
1991
ISSN/ISBN: 0024-7758 PMID: 2046079 Document Number: 378399
Document emailed within 1 workday
Related Documents
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193Friedman, A.J.; Wheeler, J. 1991: Efficacy and safety of ethynodiol diacetate 1 mg with ethynylestradiol 35 ug with an emphasis on contraceptive efficacy a phase iv trial Journal of Reproductive Medicine 36(4 Suppl): 328-333
Heber, K.R. 1968: Clinical trial of ethynodiol diacetate in a sequential oral contraceptive Medical Journal of Australia 1(8): 311-313
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Puddy, E.M. 1967: A clinical trial of the progestational steroid ethynodiol diacetate as an oral contraceptive Medical Journal of Australia 1(19): 961-967
LaGuardia, K.D.; Shangold, G.; Fisher, A.; Friedman, A.; Kafrissen, M. 2003: Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol Contraception 67(6): 431-437
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306
Reid, R.L.; Fortier, M.P.; Smith, L.; Mirkin, S.; Grubb, G.S.; Constantine, G.D. 2010: Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada Contraception 82(6): 497-502
Endrikat, J.; Jaques, M.A.; Mayerhofer, M.; Pelissier, C.; Müller, U.; Düsterberg, B. 1995: A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance Contraception 52(4): 229-235
Palli, M.B.A.; Reyes-Habito, C.M.; Lima, X.T.; Kimball, A.B. 2013: A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris Journal of Drugs in Dermatology: Jdd 12(6): 633-637
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Rúiz-Velasco, V.; Ortiz Mariscal, J.D.; Salgado, H.J.; Salinas, G.R.; Zelaya, A.P.; Partida, J.B. 1974: Ethynodiol diacetate as a contraceptive Fertility and Sterility 25(11): 927-934
Archer, D.F.; Maheux, R.; DelConte, A.; O'Brien, F.B. 1999: Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG) American Journal of Obstetrics and Gynecology 181(5 Pt 2): 39-44
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
Gidwani, G.P.; Purandare, B.N. 1968: Experience with ethynodiol diacetate and mestranol as an oral contraceptive Journal of Obstetrics and Gynaecology of India 18(2): 287-293
Zimber, M.P.; Ziering, C.; Zeigler, F.; Hubka, M.; Mansbridge, J.N.; Baumgartner, M.; Hubka, K.; Kellar, R.; Perez-Meza, D.; Sadick, N.; Naughton, G.K. 2011: Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial Journal of Drugs in Dermatology: Jdd 10(11): 1308-1312
Merkatz, R.B.; Plagianos, M.; Hoskin, E.; Cooney, M.; Hewett, P.C.; Mensch, B.S. 2014: Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction Contraception 90(5): 514-521
Elewski, B.; Ling, M.R.; Phillips, T.J. 2006: Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase IIi trial Journal of Drugs in Dermatology: Jdd 5(7): 646-650